This major statin review should help end the fear-mongering

LEADING Australian heart and vascular specialists have hailed a major review on statins published in the Lancet as a benchmark for ending ‘fear-mongering’ about the medication.

Lancet editor Dr Richard Horton says controversy over the safety and efficacy of statins has harmed the health of thousands of people and the review, which is based on evidence amassed over 30 years, should help doctors and patients make informed decisions.

The researchers’ interpretation of the evidence suggests that the use of a statin reduces the risk of major vascular events by